FIELD: medicine, pharmacy. SUBSTANCE: invention proposes a pharmaceutical composition for treatment of patients with osseous tissue loss caused by deficiency of estrogens. The composition contains raloxifene and progestin. The use of composition provides to recovery the bone density in osteoporosis. EFFECT: enhanced effectiveness of composition, valuable medicinal properties. 4 cl, 1 ex
Authors
Dates
2002-04-10—Published
1995-01-26—Filed